Nitrosamine Testing of Impurities

Health Canada recently sent a letter to Market Authorization Holders (MAHs) about nitrosamine testing of impurities in human pharmaceutical products. Nitrosamine are genotoxic compounds that are potentially carcinogenic even at low exposure levels. What the regulators are asking is for the MAHs to perform Nitrosamine testing to evaluate levels of these impurities which include [...]

Nucro-Technics at the 2019 BIO International Convention

As with every year in June, twenty thousand attendees throughout the pharmaceutical and biotech industry converge on a city in the United States for the BIO Conference. These attendees cover more than 1,000 biotech companies, academic institutions, regional hubs, and related organizations throughout Canada, the United States, and across the world. Nucro-Technics has been [...]